These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6087250)

  • 1. [Bacteriologic, clinical and kinetic evaluation of cefmenoxime (SCE 1365) in the treatment of 68 cases of septicemia. A multicenter trial].
    Bryskier A; Sollet JP; Bleichner G; Segrestaa JM; Guerin JM; Dureux JB; Canton P; Veyssier P; Lallement PY; Mottin J
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):547-51. PubMed ID: 6087250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the clinical activity of cefotiam (SCE 963). Multicentric study in 7 centers].
    Bryskier A; Humbert G; Borsa F; Bertrand A; Janbon F; Lafaix C; Beucler A; Veyssier P; Dusehu E; Modai J
    Pathol Biol (Paris); 1983 May; 31(5):328-35. PubMed ID: 6312392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of cefmenoxime in urinary tract and prostatic infections].
    Guibert J; Acar JF; Destree D; Bryskier A
    Pathol Biol (Paris); 1985 May; 33(5):330-4. PubMed ID: 3897962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefmenoxime. Clinical, bacteriologic, and pharmacologic studies.
    LeFrock JL; Molavi A; McCloskey RV; Rolston K; Chandrasekar P; Henao L; Smith BR; Kannangara W; Schell RF; Carr BB
    Am J Med; 1984 Jul; 77(1):72-8. PubMed ID: 6331163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
    Husson MO; Bryskier A; Izard D; Leclerc H
    Pathol Biol (Paris); 1983 May; 31(5):347-50. PubMed ID: 6312395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of cefmenoxime in experimental Escherichia coli bacteremia and meningitis.
    Kim KS
    Antimicrob Agents Chemother; 1985 Sep; 28(3):389-92. PubMed ID: 3907491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical studies on cefmenoxime in the intensive care unit].
    Taenaka N
    Jpn J Antibiot; 1982 Aug; 35(8):2015-21. PubMed ID: 6296478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical studies with cefmenoxime in the field of pediatrics].
    Takimoto M; Yoshioka H; Maruyama S; Sanae N; Nagamatsu I
    Jpn J Antibiot; 1982 Oct; 35(10):2379-83. PubMed ID: 6306289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transplacental passage of cefmenoxime].
    Berthelot G; Bergogne-Berezin E; Ravina JH; Vernant D; Bryskier A
    Pathol Biol (Paris); 1984 May; 32(5):322-5. PubMed ID: 6330644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cefmenoxime diffusion into cerebrospinal fluid during human purulent meningitis].
    Stahl JP; Croize J; Bru JP; Pegourie B; Blanc-Jouvan F; Bryskier A; Micoud M
    Pathol Biol (Paris); 1985 May; 33(5):365-7. PubMed ID: 3897967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of cefotiam in adults urinary tract infections (author's transl)].
    Guibert J; Coppens H; Yvelin C
    Pathol Biol (Paris); 1982 Jun; 30(6):353-6. PubMed ID: 6287388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kinetic and clinical studies on a new cephalosporin: Cefotiam].
    Soranzo ML; Capra E; Eandi M; Bosio G; Salassa B; Bendiscioli L; Bramato C; Musso E; Andreoni G; Morelli B; Fabiano A; Di Nola F; Misto P
    Minerva Med; 1982 Oct; 73(39):2671-8. PubMed ID: 6289193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study on cefmenoxime (CMX) in urology].
    Tanaka H; Kato Y; Kakinoki K; Nishio S; Maekawa M; Tsujita M; Nishijima T; Kashihara N; Kono S; Hayahara N
    Hinyokika Kiyo; 1983 Jan; 29(1):95-103. PubMed ID: 6328956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of cefmenoxime in experimental group B streptococcal bacteraemia and meningitis.
    Kim KS
    J Antimicrob Chemother; 1986 Feb; 17(2):239-44. PubMed ID: 3516964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of Cefmenoxime in normal and impaired renal function.
    Höffler D; Koeppe P
    Arzneimittelforschung; 1983; 33(2):269-72. PubMed ID: 6303362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraocular penetration of cefmenoxime (SCE-1365), A new cephalosporin, in humans.
    Takahashi N; Takahashi K; Takagi M
    Nippon Ganka Gakkai Zasshi; 1982; 86(4):337-40. PubMed ID: 6287821
    [No Abstract]   [Full Text] [Related]  

  • 18. Placental transfer of cefmenoxime in late pregnancy.
    Bergogne-Bérézin E; Bryskier A; Berthelot G; Ravina JH; Vernant D
    Chemotherapy; 1985; 31(1):1-5. PubMed ID: 3855746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of SCE-1141, a stereoisomer of cefmenoxime, in rats.
    Kita Y; Itakura K; Tsuchiya K; Imada A
    J Antimicrob Chemother; 1986 Feb; 17(2):205-13. PubMed ID: 3457784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefmenoxime therapy of serious bacterial infections.
    Gombert ME; Glasser LA; Eng RH
    Antimicrob Agents Chemother; 1984 Apr; 25(4):510-2. PubMed ID: 6329082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.